HK1161082A1 - 用於治療再灌注損傷的方法 - Google Patents
用於治療再灌注損傷的方法Info
- Publication number
- HK1161082A1 HK1161082A1 HK12101453.4A HK12101453A HK1161082A1 HK 1161082 A1 HK1161082 A1 HK 1161082A1 HK 12101453 A HK12101453 A HK 12101453A HK 1161082 A1 HK1161082 A1 HK 1161082A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methods
- reperfusion injuries
- treating reperfusion
- treating
- injuries
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8576608P | 2008-08-01 | 2008-08-01 | |
PCT/US2009/052493 WO2010014957A1 (en) | 2008-08-01 | 2009-07-31 | Methods for treating reperfusion injuries |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1161082A1 true HK1161082A1 (zh) | 2012-08-24 |
Family
ID=41610763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12101453.4A HK1161082A1 (zh) | 2008-08-01 | 2012-02-15 | 用於治療再灌注損傷的方法 |
Country Status (11)
Country | Link |
---|---|
US (4) | US8324163B2 (zh) |
EP (1) | EP2320948B1 (zh) |
JP (1) | JP5577337B2 (zh) |
CN (1) | CN102170911B (zh) |
AU (1) | AU2009276357B2 (zh) |
CA (1) | CA2732763A1 (zh) |
EA (1) | EA020579B1 (zh) |
ES (1) | ES2412237T3 (zh) |
HK (1) | HK1161082A1 (zh) |
PT (1) | PT2320948E (zh) |
WO (1) | WO2010014957A1 (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8007812B2 (en) | 2004-12-22 | 2011-08-30 | Cleveland Clinic Foundation | Flagellin related polypeptides and uses thereof |
ES2412237T3 (es) | 2008-08-01 | 2013-07-10 | Cleveland Biolabs, Inc. | Métodos para tratar lesiones por reperfusión |
KR20140030132A (ko) | 2011-01-10 | 2014-03-11 | 클리브랜드 바이오랩스, 아이엔씨. | 암을 치료하기 위한 톨-유사 수용체 효능제의 용도 |
WO2013082458A1 (en) | 2011-12-02 | 2013-06-06 | The Regents Of The University Of California | Reperfusion protection solution and uses thereof |
US20150328284A1 (en) * | 2012-04-02 | 2015-11-19 | Cleveland Biolabs, Inc | Compositions and methods comprising toll like receptor (tlr) stimulating agents for prophylaxis and therapy for damage to dermal epithelium |
JP6940916B2 (ja) * | 2014-07-30 | 2021-09-29 | ゲノム プロテクション,インコーポレイテッド | フラジェリン組成物および使用 |
WO2016109002A2 (en) | 2014-10-16 | 2016-07-07 | Cleveland Biolabs, Inc. | Methods and compositions for the treatment of radiation-related disorders |
EP3496726A4 (en) * | 2016-08-11 | 2020-05-06 | Temple University Of The Commonwealth System Of Higher Education | ISCHEMIA / REPERFUSION DAMAGE |
BR112020001088A2 (pt) | 2017-07-20 | 2020-07-21 | Spogen Biotech Inc. | polipeptídeo, composição para iniciação bioativa, micro-organismo, composição ou micro-organismo recombinante, semente, método para aumentar o crescimento e método de produção de um polipeptídeo |
CN208752357U (zh) * | 2018-09-21 | 2019-04-16 | 合肥京东方显示光源有限公司 | 背光模块及具有该背光模块的显示面板及显示器 |
KR102524577B1 (ko) | 2019-04-22 | 2023-04-21 | 전남대학교산학협력단 | 플라젤린 융합 단백질 및 이의 용도 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
US5399494A (en) | 1983-03-04 | 1995-03-21 | The University Of Maryland System | Vibrio cholerae strain CVD103Hgr, method of making same, and vaccines derived therefrom |
US6130082A (en) | 1988-05-05 | 2000-10-10 | American Cyanamid Company | Recombinant flagellin vaccines |
ES2088014T3 (es) | 1990-09-28 | 1996-08-01 | Sulzer Innotec Ag | Aguja hueca para utilizacion medica y procedimiento para la fabricacion de este tipo de agujas huecas. |
EP0967279B1 (en) | 1992-03-02 | 2008-01-02 | Novartis Vaccines and Diagnostics S.r.l. | Helicobacter pylori cytotoxin useful for vaccines and diagnostics |
US5693476A (en) | 1995-02-24 | 1997-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of screening for compounds capable of modulating vesicular release |
US20020009747A1 (en) | 1997-08-25 | 2002-01-24 | Freda Diane Miller | Methods and reagents for identifying modulators of neuronal apoptosis |
US5994409A (en) | 1997-12-09 | 1999-11-30 | U.S. Bioscience, Inc. | Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds |
WO2001040280A2 (en) | 1999-11-29 | 2001-06-07 | Inotek Corporation | Composition and method for treating a microbial infection |
CN1447819B (zh) | 2000-01-31 | 2011-06-22 | 妙甯公司 | 人cyr61 |
US7300749B2 (en) | 2000-02-17 | 2007-11-27 | Millennium Pharmaceuticals, Inc. | Molecules of the pyrin domain protein family and uses thereof |
AU2002216500A1 (en) | 2000-11-28 | 2002-06-11 | Genesis Research And Development Corporation Limited | Methods for modulating apoptotic cell death |
US8703146B2 (en) | 2001-04-20 | 2014-04-22 | Institute For Systems Biology | Toll-like receptor 5 ligands and methods of use |
DE60141773D1 (de) | 2001-04-20 | 2010-05-20 | Inst Systems Biology | Toll-ähnlichen-rezeptor-5-liganden und verwendungsverfahren |
CA2462638A1 (en) | 2001-10-02 | 2003-04-10 | University Of Chicago | Methods and compositions for modulating apoptosis |
US7078165B2 (en) | 2003-03-27 | 2006-07-18 | Institut Pasteur | Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof |
WO2005056041A2 (en) | 2003-12-02 | 2005-06-23 | Cleveland Clinic Foundation | METHODS OF INHIBITING APOPTOSIS USING LATENT TGFβ |
US7638485B2 (en) | 2003-12-02 | 2009-12-29 | Cleveland Biolabs, Inc. | Modulating apoptosis |
WO2005056054A2 (en) | 2003-12-02 | 2005-06-23 | Cleveland Clinic Foundation | METHODS OF INHIBITING APOPTOSIS USING INDUCERS OF NF-κB |
US8580321B2 (en) | 2003-12-02 | 2013-11-12 | The Cleveland Clinic Foundation | Method for reducing the effects of chemotherapy using flagellin related polypeptides |
UA83272C2 (uk) | 2003-12-02 | 2008-06-25 | Клевеленд Клінік Фаундейшн | Спосіб захисту від ефектів іонізуючого випромінювання за допомогою флагеліну |
US20050266391A1 (en) * | 2004-01-15 | 2005-12-01 | Bennett Brydon L | Methods for preserving tissue |
JP5094407B2 (ja) | 2004-12-16 | 2012-12-12 | ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ | Yersiniapestisの免疫療法におけるフラジェリンの使用 |
US8007812B2 (en) * | 2004-12-22 | 2011-08-30 | Cleveland Clinic Foundation | Flagellin related polypeptides and uses thereof |
WO2007030581A2 (en) * | 2005-09-09 | 2007-03-15 | Oregon Health & Science University | Neuroprotectants |
US20070269406A1 (en) | 2005-12-14 | 2007-11-22 | Ichim Thomas E | Transcatheter tumor immunoembolization |
AU2007239095B2 (en) | 2006-01-09 | 2012-05-03 | The Regents Of The University Of California | Immunostimulatory combinations for vaccine adjuvants |
EP2114427B1 (en) | 2007-01-30 | 2014-06-25 | New York University | Peptides for treatment of conditions associated with nitric oxide |
JP2010535248A (ja) | 2007-07-31 | 2010-11-18 | ザ ジョンズ ホプキンス ユニバーシティー | 腫瘍性障害または感染症の免疫学的予防または免疫療法のためのポリペプチド−核酸複合体 |
KR101811965B1 (ko) | 2007-11-07 | 2017-12-22 | 셀덱스 쎄라퓨틱스, 인크. | 인간 수지상 및 상피 세포 205(dec-205)에 결합하는 항체 |
ES2412237T3 (es) | 2008-08-01 | 2013-07-10 | Cleveland Biolabs, Inc. | Métodos para tratar lesiones por reperfusión |
CN104136614B (zh) | 2009-10-06 | 2018-04-06 | 帕纳塞拉实验室有限责任公司 | Toll‑样受体和激动剂用于治疗癌症的用途 |
-
2009
- 2009-07-31 ES ES09803688T patent/ES2412237T3/es active Active
- 2009-07-31 JP JP2011521369A patent/JP5577337B2/ja not_active Expired - Fee Related
- 2009-07-31 US US13/056,973 patent/US8324163B2/en not_active Expired - Fee Related
- 2009-07-31 WO PCT/US2009/052493 patent/WO2010014957A1/en active Application Filing
- 2009-07-31 EA EA201170294A patent/EA020579B1/ru not_active IP Right Cessation
- 2009-07-31 PT PT98036882T patent/PT2320948E/pt unknown
- 2009-07-31 AU AU2009276357A patent/AU2009276357B2/en not_active Ceased
- 2009-07-31 CN CN200980138907.1A patent/CN102170911B/zh not_active Expired - Fee Related
- 2009-07-31 CA CA 2732763 patent/CA2732763A1/en not_active Abandoned
- 2009-07-31 EP EP20090803688 patent/EP2320948B1/en not_active Not-in-force
-
2012
- 2012-02-15 HK HK12101453.4A patent/HK1161082A1/zh not_active IP Right Cessation
- 2012-06-22 US US13/530,580 patent/US8618059B2/en not_active Expired - Fee Related
-
2013
- 2013-11-22 US US14/088,097 patent/US9006180B2/en not_active Expired - Fee Related
-
2015
- 2015-03-11 US US14/645,212 patent/US20150182587A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EA020579B1 (ru) | 2014-12-30 |
JP5577337B2 (ja) | 2014-08-20 |
PT2320948E (pt) | 2013-06-17 |
EP2320948A4 (en) | 2012-01-25 |
AU2009276357A1 (en) | 2010-02-04 |
US8324163B2 (en) | 2012-12-04 |
WO2010014957A1 (en) | 2010-02-04 |
US9006180B2 (en) | 2015-04-14 |
EP2320948A1 (en) | 2011-05-18 |
CN102170911B (zh) | 2014-07-02 |
US20110135665A1 (en) | 2011-06-09 |
AU2009276357B2 (en) | 2014-09-11 |
US8618059B2 (en) | 2013-12-31 |
ES2412237T3 (es) | 2013-07-10 |
CA2732763A1 (en) | 2010-02-04 |
CN102170911A (zh) | 2011-08-31 |
US20150182587A1 (en) | 2015-07-02 |
US20140220037A1 (en) | 2014-08-07 |
US20130004515A1 (en) | 2013-01-03 |
EA201170294A1 (ru) | 2011-08-30 |
JP2011529922A (ja) | 2011-12-15 |
EP2320948B1 (en) | 2013-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL257418A (en) | Methods for treating addiction | |
HK1161082A1 (zh) | 用於治療再灌注損傷的方法 | |
IL209895A0 (en) | Compounds for treating beta-amyloidoses | |
IL212348A0 (en) | Treatment method | |
HK1167082A1 (zh) | 治療局部缺血和缺血-再灌注損傷的組合物與方法 | |
SI2349132T1 (sl) | Naprava za zdravljenje GERB-a | |
PT2248083T (pt) | Método de autenticação | |
GB0802116D0 (en) | Treatment | |
IL213619A0 (en) | Treatment | |
EP2282826A4 (en) | PROCESS FOR TREATMENT OF ODOR | |
GB0822011D0 (en) | Treatment | |
IL211774A (en) | Animal Care Device | |
GB0819008D0 (en) | Process | |
HK1203516A1 (zh) | 治療乾癬的方法 | |
EP2311711A4 (en) | CONTROL UNIT | |
EP2341936A4 (en) | METHOD FOR TREATING OR PREVENTING IL-1ß-CONTAINED ILLNESSES | |
GB0801209D0 (en) | Process | |
EP2453896A4 (en) | PROCESS FOR TREATING SCHIZOPHRENIA | |
GB0811992D0 (en) | Treatment | |
GB0800875D0 (en) | Process | |
EP2296461A4 (en) | METHODS OF TREATING ARTHROPODS | |
EP2292495A4 (en) | STEERING APPARATUS | |
GB0820972D0 (en) | Treatment | |
IL213287A0 (en) | Treatment for glomerulonephritis | |
GB0805912D0 (en) | Treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20180731 |